Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
345 Phase I/II trial of cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies (CAMILLA): phase Ib safety and efficacy results
Compose a Response to This Article
Other responses
No responses have been published for this article.